Remove 2023 Remove Competition Remove Leads
article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

article thumbnail

9 Healthcare Marketing Trends to Embrace in 2023

Healthcare Success

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Competition from Retail and Telehealth Disruptors Continues to Intensif y. Focus on these key audiences to stay competitive: a.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

Biopharma sees strong Q2 2023 market cap growth

European Pharmaceutical Review

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. billion to revenue in Q2 2023. billion to revenue in Q2 2023. billion in Q2 2023. percent.

article thumbnail

What Role Does Healthcare SEO Play in a 2023 Marketing Strategy?

LEVO Health

Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan. In turn, this may lead to more patients visiting your website and ultimately booking appointments at your practice.

article thumbnail

Major M&A deals on 2023 agenda, says report

European Pharmaceutical Review

Record levels of deal-making Firepower, a company’s capacity to do M&A based on the strength of its balance sheet, is available for the life sciences sector, according to EY’s 2023 M&A Firepower report. M&A predictions for 2023. Global M&A activity in 2022.

article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.